Constipation-predominant Irritable Bowel Syndrome
17
0
0
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
17.6%
3 terminated out of 17 trials
70.0%
-16.5% vs benchmark
18%
3 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (17)
MOWOOT Device Treatment for Adults With Chronic Constipation
Soluble and Osmotic Fibre (SOLOS) Diet for Constipation
A Chinese Herbal Medicine for IBS-C
To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome
Laser Acupuncture on Irritable Bowel Syndrome in Females
Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations
Anorectal Manometry of Patients With Constipation Predominant IBS
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation
Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome
Assessment of Responsiveness to Treatment by Experience Sampling Method
Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
Cheno Effect on Transit in Health and IBS-C
Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)